Picture of Procaps SA logo

PROC Procaps SA Share Price

0.000.00%
us flag iconLast trade - 00:00
FinancialsBalancedMid CapNeutral

Momentum

Relative Strength (%)
1m-14.69%
3m-20.13%
6m-30.66%
1yr-19.34%
Volume Change (%)
10d/3m+51.03%
Price vs... (%)
52w High-40.9%
50d MA-8.68%
200d MA-22%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)13.18
PEG Ratio (f)0.22
EPS Growth (f)149.23%
Dividend Yield (f)n/a
Valuation (ttm)IndustryMarket
Price to Book Valuen/a
Price to Tang. Bookn/a
Price to Free Cashflow54.74
Price to Sales1.71
EV to EBITDA10.81

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital27.99%
Return on Equityn/a
Operating Margin17.2%

Financial Summary

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202231st Dec 2023
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2022 / 2023

Blurred out image of Procaps SA EPS forecast chart

Profile Summary

Procaps Group SA is a Luxembourg-based healthcare and pharmaceutical company. The Company develops, manufactures and sells prescription drugs and products that are differentiated by their combinations and pharmaceutical forms, as well as nutritional supplements which include omega 3 fish oils and high-potency clinical compounds. It operates its business through 5 units which are Diabetrics, Farma Procaps, Softi Gel, Vital Care, and Clinical Specialties. Diabetrics provides diabetes solutions. Farma procaps formulates, manufactures and markets branded prescription drugs in Latin America. Softi Gel provides contract drug development and manufacturing services to third party pharmaceutical companies. Vital Care develops, manufactures and markets consumer healthcare products. Clinical Specialties develops, manufactures and markets complex drugs.

Directors

    Last Annual
    December 31st, 2021
    Last Interim
    September 30th, 2022
    Incorporated
    April 8th, 2021
    Public Since
    July 22nd, 2021
    No. of Employees
    4,900
    Sector
    Holding Companies
    Industry
    Financials
    Exchange
    us flag iconNASDAQ Global Market
    Shares in Issue
    112,824,183

    PROC Share Price Performance

    Upcoming Events for PROC

    Similar to PROC

    Picture of 7 Acquisition logo

    7 Acquisition

    us flag iconNASDAQ Global Market

    Picture of 7 Acquisition logo

    7 Acquisition

    us flag iconNASDAQ Global Market

    Picture of Accretion Acquisition logo

    Accretion Acquisition

    us flag iconNASDAQ Global Market

    Picture of Accretion Acquisition logo

    Accretion Acquisition

    us flag iconNASDAQ Global Market

    Picture of Accretion Acquisition logo

    Accretion Acquisition

    us flag iconNASDAQ Global Market

    FAQ

    Or unlock with your email

    Or unlock with your email